A Clinical Study Comparing the Comfort of Three Commercially Available Contact Lenses

Ora, Inc.

Status: Withdrawn

Conditions: Contact Lens Complication

Treatments: Device: Acuvue® Oasys® Lenses (senofilcon A); Device: 30-Day Bausch + Lomb PureVision (balafilcon A); Device: Clariti® 1-Day (Somofilcon A)

Study type: Interventional

Funder types: Industry

Identifiers

NCT02298400

14-270-0001

Details and patient eligibility

About

The purpose of this study is to compare the comfort of three commercially available contact lenses.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Be at least 18 years old
• Have provided written informed consent
• Have discomfort when wearing contact lenses

Exclusion criteria

• Have an active ocular infection or significant slit lamp findings
• Participated in any other studies in the past 30 days

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Double Blind

---

0 participants in 3 patient groups

Acuvue®Oasys® Lenses(senofilcon A)

Active Comparator group

Description:

Acuvue® Oasys® Lenses (senofilcon A) contact lenses

Treatment:

Device: Clariti® 1-Day (Somofilcon A)

Device: 30-Day Bausch + Lomb PureVision (balafilcon A)

Device: Acuvue® Oasys® Lenses (senofilcon A)

Bausch + Lomb PureVision (balafilcon A)

Active Comparator group

Description:

30-Day Bausch + Lomb PureVision (balafilcon A) contact lenses

Treatment:

Device: Clariti® 1-Day (Somofilcon A)

Device: 30-Day Bausch + Lomb PureVision (balafilcon A)

Device: Acuvue® Oasys® Lenses (senofilcon A)

Clariti® 1-Day (Somofilcon A)

Active Comparator group

Description:

Clariti® 1-Day (Somofilcon A) contact lenses

Treatment:

Device: Clariti® 1-Day (Somofilcon A)

Device: 30-Day Bausch + Lomb PureVision (balafilcon A)

Device: Acuvue® Oasys® Lenses (senofilcon A)